Light Therapy for Patients With Bipolar Depression: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 11 of the 41 sources its claims cite were checked for support.
Abstract
Objective Bipolar disorder (BD) is challenging to treat, and fewer treatments are available for depressive episodes compared to mania. Light therapy is an evidence-based nonpharmacological treatment for seasonal and nonseasonal major depression, but fewer studies have examined its efficacy for patients with BD. Hence, we reviewed the evidence for adjunctive light therapy as a treatment for bipolar depression. Methods We conducted a systematic review of databases from inception to June 30, 2019, for randomized, double-blind, placebo-controlled trials of light therapy in patients with BD (CRD42019128996). The primary outcome was change in clinician-rated depressive symptom score; secondary outcomes included clinical response, remission, acceptability, and treatment-emergent mood switches. We quantitatively pooled outcomes using meta-analysis with random-effects models. Results We identified seven trials representing 259 patients with BD. Light therapy was associated with a significant improvement in Hamilton Depression Rating Scale score (standardized mean difference = 0.43, 95% confidence interval [CI], 0.04 to 0.82, P = 0.03). There was also a significant difference in favor of light therapy for clinical response (odds ratio [ OR] = 2.32; 95% CI, 1.12 to 4.81; P = 0.024) but not for remission. There was no difference in affective switches between active light and control conditions ( OR = 1.30; 95% CI, 0.38 to 4.44; P = 0.67). Study limitations included different light treatment parameters, small sample sizes, short treatment durations, and variable quality across trials. Conclusion There is positive but nonconclusive evidence that adjunctive light therapy reduces symptoms of bipolar depression and increases clinical response. Light therapy is well tolerated with no increased risk of affective switch.
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis found that adjunctive light therapy for bipolar depression had positive but nonconclusive evidence: it improved clinician-rated depressive symptoms and clinical response, with no detected increase in affective switch. The evidence base was small and heterogeneous, with 7 trials and 259 participants.
## Key findings
- Across 7 trials (259 participants), active light therapy improved clinician-rated depressive symptoms on the HAM-D versus control: SMD 0.43, 95% CI 0.04 to 0.82, P = 0.03.
- Clinical response favored light therapy in 6 trials: pooled OR 2.32, 95% CI 1.12 to 4.81, P = 0.024; overall response rates were 64.3% with active light vs 42.9% with control.
- Clinical remission was not statistically significant in 5 trials: pooled OR 3.21, 95% CI 0.83 to 12.4, P = 0.09; remission rates were 40.7% vs 16.9%.
- No significant increase in affective switch was found in 7 trials: OR 1.30, 95% CI 0.38 to 4.44, P = 0.67; switch rates were 3.0% vs 1.6%.
## Methods
- Systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of adjunctive light therapy in patients with bipolar disorder in a depressive episode; registered at PROSPERO (CRD42019128996).
- Searches covered inception to June 30, 2019 across Web of Science, EMBASE, Medline, PsycInfo, and Clinicaltrials.gov, plus reference chaining and Google Scholar.
- Primary analysis pooled endpoint clinician-rated depressive symptom change using standardized mean differences with random-effects models; secondary outcomes included response, remission, discontinuation, and treatment-emergent mood switches.
## Limitations
- The paper states the included studies had variable quality, heterogeneous light parameters, small sample sizes, short follow-up, and some control conditions may have had active effects.
- Risk of bias was high or unclear in at least one major category across studies; 4 of 7 trials did not report allocation concealment, and only 4 reported blinded outcome raters.
- Evident from the text: most participants were also taking concomitant medications and the studies did not separate BD-I from BD-II data, limiting subgroup-specific inference.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 13 Not checked · 77 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Only one study prospectively controlled for medication use by stratifying randomization based on whether antidepressants were used or not. 27”
What the sources say
- Partly supportedcites [27] sourceExperimental — accuracy not yet measured
The Procedures passage says patients were randomized to active or inactive light therapy and stratified by antidepressant use, supporting the description of this study's design. The paper does not establish that it was the only study to use that approach. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“six studies 25-29,31 did not observe any switches in either active light or control conditions”
What the sources say
- Not checked — no full text of the sourcecites [25] source
- Not checked — no full text of the sourcecites [26] source
- Supportedcites [27] source
The Primary Outcome Measures section reports that no hypomania or mood polarity switch was observed. The Procedures section identifies both active bright-white-light and inactive dim-red-light groups, supporting this paper’s contribution to the citing sentence; the count of six studies is the citing authors’ synthesis, not a finding attributed to this trial alone. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [28] source
- Not checked — no full text of the sourcecites [29] source
- Not checked — no full text of the sourcecites [31] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Light therapy was associated with a significant improvement in Hamilton Depression Rating Scale score (standardized mean difference ¼ 0.43, 95% confidence interval [CI], 0.04 to 0.82, P ¼ 0.03).”
plainstates an associationn = 259 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“one study 25 used a quasi-randomized design in which patients were randomized according to the day of week that they were admitted to an inpatient unit.”
What the sources say
- Not checked — no full text of the sourcecites [25] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was also a significant difference in favor of light therapy for clinical response (odds ratio [ OR ] ¼ 2.32; 95% CI, 1.12 to 4.81; P ¼ 0.024) but not for remission.”
plainstates an associationn = 259 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
35 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 34
- It may state two separate claims as one. 39
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Symptomatic remission should be expected by four to six weeks of treatment (Sit et al. 2018; Lam et al. 2020).”
From Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force (2025) · cites this paper as Lam et al. 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypomanic symptoms that appear during BLT can resolve with a simple decrease in dosage (duration and/or intensity) or by stopping BLT if it is not enough to quickly reduce (hypo)manic symptoms (Sit et al. 2007; Lam et al. 2020; Geoffroy et al. 2025).”
From Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force (2025) · cites this paper as Lam et al. 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Suicidal ideation and mood induction are uncommon outcomes of BLT (Sit and Haigh 2019; Lam et al. 2020).”
From Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force (2025) · cites this paper as Lam et al. 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in the case of Bright Light Therapy there are now at least eight randomised controlled trials (RCTs) suggesting its efficacy, safety, and tolerability in the treatment of bipolar depression [26, 27]”
From Essential Information About Chronobiology and Chronotherapy for the Optimal Care of People With Bipolar Disorders: An Expert Consensus (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“some meta-analysis have suggested that BLT is effective [42–45]”
From Bright light therapy in the treatment of patients with bipolar disorder: A systematic review and meta-analysis (2020) · cites this paper as [42]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.12 · Cited by 2,627
Rosenthal, N. E. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790120076010 · Cited by 2,385
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852 · cited 1×
“Bipolar depression is challenging to treat, and there are fewer available treatments for bipolar depression compared to mania.(7) Hence, additional evidence-based treatment options for bipolar depression is a recognized unmet need.”
BackgroundSelf-citationJudd, L. L., Akiskal, H. S., Schettler, P. J., Coryell, W., Endicott, J., Maser, J. D., Solomon, D. A., Leon, A. C., & Keller, M. B. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.261 · Cited by 1,243 · cited 1×
“Much of this disease burden is associated with depressive episodes,(3,4) which dominate the episode course of BD and are more frequent and longer in duration than manic or hypomanic episodes.(5,6) Bipolar depression is challenging to treat, and there are fewer available treatments for bipolar depression compared to ma…”
BackgroundKessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1561 · Cited by 868
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1561 · Cited by 868
The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013
Ferrari, A. J., Stockings, E., Khoo, J., Erskine, H. E., Degenhardt, L., Vos, T., & Whiteford, H. A. (2016) · Bipolar Disorders · doi:10.1111/bdi.12423 · Cited by 583
Light Therapy for Seasonal and Nonseasonal Depression: Efficacy, Protocol, Safety, and Side Effects
Terman, M., & Terman, J. S. (2005) · CNS Spectrums · doi:10.1017/s1092852900019611 · Cited by 546 · cited 1×
“Light therapy is generally well tolerated by patients, often with milder side effects than medications.(11) The mechanism of action of light therapy is not yet clearly elucidated, but major hypotheses involve chronobiological effects of light(12) and effects on neurotransmitters such as serotonin.”
BackgroundRavindran, A. V., Balneaves, L. G., Faulkner, G., Ortiz, A., McIntosh, D., Morehouse, R. L., Ravindran, L., Yatham, L. N., Kennedy, S. H., Lam, R. W., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716660290 · Cited by 337
Self-citationPractical guide to the meta-analysis of rare events
Efthimiou, O. (2018) · Evidence Based Mental Health · doi:10.1136/eb-2018-102911 · Cited by 231
Sit, D. K., McGowan, J., Wiltrout, C., Diler, R. S., Dills, J. (., Luther, J., Yang, A., Ciolino, J. D., Seltman, H., Wisniewski, S. R., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16101200 · Cited by 186 · cited 2×
“The durations of follow-up in these studies were also short, with only two studies using a more typical acute treatment follow up of 6–8 weeks.(27,30) Given the cyclical nature of BD, future studies will need to provide longer follow-up periods for acute light treatment.”
MethodSelf-citationLight therapy for non-seasonal depression: systematic review and meta-analysis
Perera, S., Eisen, R., Bhatt, M., Bhatnagar, N., de Souza, R., Thabane, L., & Samaan, Z. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.115.001610 · Cited by 153
Morning Light Treatment Hastens the Antidepressant Effect of Citalopram: A Placebo-Controlled Trial
Benedetti, F., Colombo, C., Pontiggia, A., Bernasconi, A., Florita, M., & Smeraldi, E. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0605 · Cited by 152 · cited 1×
“, 400 lux) may have therapeutic effects.(29) Non-light control conditions do not conflate dosing of light but they introduce a different type of treatment device that may have different expectations from participants.”
BackgroundPredictors of response and nonresponse to light treatment for winter depression
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.11.1423 · Cited by 124
Light therapy in the treatment of patients with bipolar depression: A meta-analytic study
Tseng, P.-T., Chen, Y.-W., Tu, K.-Y., Chung, W., Wang, H.-Y., Wu, C.-K., & Lin, P.-Y. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.001 · Cited by 100 · cited 1×
“A previous systematic review of light therapy studies in bipolar depression (with literature search up to October, 2015) did not identify any randomized controlled trials (RCTs), and the quantitative meta-analysis only examined pre–post effect sizes from open-label studies.(17) Given that several RCTs have since been…”
BackgroundPenders, T. M., Stanciu, C. N., Schoemann, A. M., Ninan, P. T., Bloch, R., & Saeed, S. A. (2016) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.15r01906 · Cited by 77
Dauphinais, D. R., Rosenthal, J. Z., Terman, M., DiFebo, H. M., Tuggle, C., & Rosenthal, N. E. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.01.015 · Cited by 63
Zhou, T.-H., Dang, W.-M., Ma, Y.-T., Hu, C.-Q., Wang, N., Zhang, G.-Y., Wang, G., Shi, C., Zhang, H., Guo, B., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.038 · Cited by 53 · cited 1×
“Three studies examined medication use retrospectively and found no differences between conditions.(25,28,31) Figure 4.”
BackgroundEfficacy of bright light therapy in bipolar depression
Yorguner Kupeli, N., Bulut, N. S., Carkaxhiu Bulut, G., Kurt, E., & Kora, K. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.020 · Cited by 51
Serotonin transporter binding is reduced in seasonal affective disorder following light therapy
Tyrer, A. E., Levitan, R. D., Houle, S., Wilson, A. A., Nóbrega, J. N., Rusjan, P., & Meyer, J. H. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12632 · Cited by 47
Rate of switch from bipolar depression into mania after morning light therapy: A historical review
Benedetti, F. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.01.013 · Cited by 39 · cited 7×
“A previous systematic review of light therapy studies in bipolar depression (with literature search up to October, 2015) did not identify any randomized controlled trials (RCTs), and the quantitative meta-analysis only examined pre–post effect sizes from open-label studies.17 Given that several RCTs have since been pu…”
ResultInfluentialUse of “Lights” for Bipolar Depression
Sit, D., & Haigh, S. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1025-0 · Cited by 37
Self-citationCurrent landscape, unmet needs, and future directions for treatment of bipolar depression
Frye, M. A., Prieto, M. L., Bobo, W. V., Kung, S., Veldic, M., Alarcon, R. D., Moore, K. M., Choi, D.-S., Biernacka, J. M., & Tye, S. J. (2014) · Journal of Affective Disorders · doi:10.1016/s0165-0327(14)70005-9 · Cited by 36
A sham-controlled randomized trial of adjunctive light therapy for non-seasonal depression
Chojnacka, M., Antosik-Wójcińska, A. Z., Dominiak, M., Bzinkowska, D., Borzym, A., Sokół-Szawłowska, M., Bodzak-Opolska, G., Antoniak, D., & Święcicki, Ł. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.062 · Cited by 32 · cited 1×
“Three studies examined medication use retrospectively and found no differences between conditions.(25,28,31) Figure 4.”
BackgroundSystemic challenges in bipolar disorder management: A patient‐centered approach
Nestsiarovich, A., Hurwitz, N. G., Nelson, S. J., Crisanti, A. S., Kerner, B., Kuntz, M. J., Smith, A. N., Volesky, E., Schroeter, Q. L., DeShaw, J. L., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12547 · Cited by 30 · cited 1×
“Alternative and nonpharmacological treatments are also identified by patients as a research priority.(9) Light therapy, consisting of daily exposure to bright artificial light, is an evidence-based nonpharmacological treatment for seasonal and nonseasonal major depressive disorder (MDD) that has a low side effect burd…”
BackgroundDimitrova, T. D., Reeves, G. M., Snitker, S., Lapidus, M., Sleemi, A. R., Balis, T. G., Manalai, P., Tariq, M. M., Cabassa, J. A., Karim, N. N., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.038 · Cited by 16
A Clinician's Guide to Using Light Therapy
Tam, E. M., & Lam, R. W. M. (2018) · Cited by 14
Self-citationLevitan, R. D., Levitt, A. J., Michalak, E. E., Morehouse, R., Ramasubbu, R., Yatham, L. N., Tam, E. M., & Lam, R. W. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11856 · Cited by 8
Self-citation
Research works printed but not linked: 2
- Penders TM, 2016, Prim Care Companion CNS Disord, 18
- Higgins J, 2011, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]
Cited by
Crouse, J. J., Carpenter, J. S., Song, Y. J. C., Hockey, S. J., Naismith, S. L., Grunstein, R. R., Scott, E. M., Merikangas, K. R., Scott, J., & Hickie, I. B. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00034-1 · Cited by 255
Circadian rhythms and mood disorders: Time to see the light
Dollish, H. K., Tsyglakova, M., & McClung, C. A. (2024) · Neuron · doi:10.1016/j.neuron.2023.09.023 · Cited by 167
Biological rhythms and chronotherapeutics in depression
Geoffroy, P. A., & Palagini, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110158 · Cited by 127
Circadian depression: A mood disorder phenotype
Carpenter, J. S., Crouse, J. J., Scott, E. M., Naismith, S. L., Wilson, C., Scott, J., Merikangas, K. R., & Hickie, I. B. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.045 · Cited by 114
Rosson, S., de Filippis, R., Croatto, G., Collantoni, E., Pallottino, S., Guinart, D., Brunoni, A. R., Dell’Osso, B. M., Pigato, G., Hyde, J., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104743 · Cited by 133
Metadata
- Authors
- Lam, R. W., Teng, M. Y., Jung, Y.-E., Evans, V. C., Gottlieb, J. F., Chakrabarty, T., Michalak, E. E., Murphy, J. K., Yatham, L. N., & Sit, D. K.
- Affiliations
- University of British Columbia (CA)
- Northwestern University (US)
- Corresponding author
- Lam, Raymond W.
- ORCID
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2019-12-12
- Volume
- 65
- Issue
- 5
- Pages
- 290-300
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- PMC
- PMC7265610
- OpenAlex
- W2996702796
- Cited by
- 70
- References
- 35
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 6 · 2023: 10 · 2022: 10 · 2021: 11 · 2020: 2
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- phototherapy, bipolar depression, bipolar disorder, adjunctive therapy, depressive symptoms, clinical response, mood switching, treatment acceptability, non-pharmacological treatment
- MeSH terms
- Bipolar Disorder, Major Depressive Disorder, Double-Blind Method, Humans, Phototherapy, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.